8SJK
Pembrolizumab Caffeine crystal
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 22-ID |
| Synchrotron site | APS |
| Beamline | 22-ID |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2017-07-01 |
| Detector | DECTRIS PILATUS 6M |
| Wavelength(s) | 1. |
| Spacegroup name | P 2 2 21 |
| Unit cell lengths | 43.800, 113.900, 175.000 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 40.810 - 2.220 |
| R-factor | 0.189 |
| Rwork | 0.186 |
| R-free | 0.23800 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.010 |
| RMSD bond angle | 1.130 |
| Data reduction software | XDS |
| Data scaling software | Aimless (8.5.28) |
| Phasing software | MOLREP (11.4.06) |
| Refinement software | BUSTER (2.11.7) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 40.810 | 2.453 |
| High resolution limit [Å] | 2.220 | 2.220 |
| Rmerge | 0.138 | 0.904 |
| Rmeas | 0.147 | 0.147 |
| Rpim | 0.048 | |
| Number of reflections | 33863 | 2412 |
| <I/σ(I)> | 14.1 | 1.3 |
| Completeness [%] | 99.7 | 15.1 |
| Redundancy | 8.7 | 3.7 |
| CC(1/2) | 0.995 | 0.542 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION | 6.8 | 300 | 0.1M Na HEPES pH 6.8 0.2%W/V Caffeine, 12% PEG3350, 3% DEXTRAN |






